title: [Clinical-genetic care of BRCA-mutation carrier women: prevention, diagnosis and therapy].
abstract: Predictive genetics opens a considerable perspective in the diagnostics as well as the treatment of breast and ovarian cancer. Current recommendations and guidelines for the management of BRCA 1 and BRCA 2 mutation carriers are not based on controlled randomized trials, but on expert opinions. The existing options of prevention, early diagnosis and treatment must be clearly interpreted to the patient. In the context of a dedicated genetic counseling the participation of all involved professionals (geneticist, oncologist, surgeon, gynecologist) is required. The decision-making process concerning the possibilities of prevention, diagnosis and treatment is always deeply influenced by the patient's own experience with the cancer occurred in the family, as well as by her values and expectations of life. The focused multidisciplinary approach, with the application of results from prospective studies in cohorts of BRCA mutation carriers allow the concerned individuals to benefit from this kind of approach of medical treatment.
authors: NAGY GÉN Diagnosztikai és Kutatási Kft. Budapest.
authors: Zsolt
authors: Z
authors: Nagy
authors: Mónika
authors: M
authors: Csanád
authors: Katalin
authors: K
authors: Tóth
authors: Szabolcs
authors: S
authors: Máté
authors: József Gábor
authors: JG
authors: Joó